Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, and RNA modifications and cancer.
Neutrophils’ dual role in cancer: from tumor progression to immunotherapeutic potential
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers
Shedding light on macrophage immunotherapy in lung cancer
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
<scp>UBE2V2</scp> promotes metastasis by regulating <scp>EMT</scp> and predicts a poor prognosis in lung adenocarcinoma
Establishment of Ferroptosis-Associated Molecular Subtypes and Hub Genes Related to the Immune Microenvironment of Heart Failure
Single-Cell Sequencing Analysis and Multiple Machine Learning Methods Identified G0S2 and HPSE as Novel Biomarkers for Abdominal Aortic Aneurysm
Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer
AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response